Tag: Heart Failure
ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure
Semaglutide reduces body weight to a greater extent in females; yields similar improvements in heart failure-related symptoms in both sexes
Triglyceride-Glucose Index Independently Linked to All-Cause Mortality
Association with in-hospital and one-year mortality seen for patients with heart failure and chronic kidney disease
Diet-Induced Inflammation Positively Tied to Marker of Heart Failure
Link seen between Dietary Inflammatory Index and N-terminal pro B-type natriuretic peptide
Risk for Kidney Complications Increased After Heart Failure Hospitalization
By one year after heart failure hospitalization, 6 percent had progressed to dialysis, 7 percent had been readmitted for AKI
Semaglutide Reduces Need for Diuretics in Heart Failure
Medication also has beneficial effect on change in body weight across diuretic use categories
Male, Female V1421 Carriers Face Similar Risk for Heart Failure Hospitalization
Carriers face similar and substantial risk for heart failure hospitalization, mainly with reduced ejection fraction
Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure
Study involved seven children weighing 8 to 30 kg; all children survived, five to transplant and one to recovery
Early Dapagliflozin Does Not Impact Diuretic Efficiency in Acute Heart Failure
Loop diuretic doses reduced and median 24-hour natriuresis and urine output improved in association with dapagliflozin
Gains in Heart Failure Mortality Have Been Erased
Declines in heart failure mortality rates from 1999 to 2012 reversed from 2012 to 2021
